Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia

被引:33
作者
Giovannetti, Elisa [2 ]
Ugrasena, Dewa G. [3 ]
Supriyadi, Eddy [4 ]
Vroling, Laura [2 ]
Azzarello, Antonino [2 ]
de lange, Desiree [1 ]
Peters, Godefridus J. [2 ]
Veerman, Anjo J. P. [1 ]
Cloos, Jacqueline [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, VU Inst Canc & Immunol, Dept Paediat Oncol Hematol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, VU Inst Canc & Immunol, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands
[3] Airlangga Univ Surabaya, Dept Child Hlth, Surabaya, Indonesia
[4] Gadjah Mada Univ, Dept Paediat Hematooncol, Yogyakarta, Indonesia
关键词
acute lymphoblastoid leukernia; paediatric patients; methotrexate; MTHFR C677T; TSER; 2R/3R; Indonesia;
D O I
10.1016/j.leukres.2007.02.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic variations in the polymorphic tandem repeat sequence of the enhancer region of the thymidylate synthase promoter(TSER), as we] I as in methylenetetrahydrofolate reduclase (MTHFR) C677T polymorphism, influence methotrexate sensitivity. We studied these polymorphisms in children with acute lymphoblastic leukaemia (ALL) and in subjects without malignancy in Indonesia and Holland. The frequencies of 77 and CT genotypes were two-fold higher in Dutch children. The TSER 3R/3R repeat was three-fold more frequent in the Indonesian children, while the 2R/2R repeat was only 1% compared to 21% in the Dutch children. No differences of these polymorphisms were found between ALL cells and normal blood cells, indicating an ethnic rather than leukemic origin. These results may have implications for treatment of Indonesian children with ALL. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 27 条
  • [1] Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia
    Aplenc, R
    Thompson, J
    Han, P
    La, M
    Zhao, HQ
    Lange, B
    Rebbeck, T
    [J]. CANCER RESEARCH, 2005, 65 (06) : 2482 - 2487
  • [2] Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics
    Bauduer, F
    Lacombe, D
    [J]. MOLECULAR GENETICS AND METABOLISM, 2005, 86 (1-2) : 91 - 99
  • [3] Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression
    Bolufer, Pascual
    Barragan, Eva
    Collado, Maria
    Cervera, Jose
    Lopez, Jose-Antonio
    Sanz, Miguel A.
    [J]. LEUKEMIA RESEARCH, 2006, 30 (12) : 1471 - 1491
  • [4] Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate
    Chiusolo, P
    Reddiconto, G
    Casorelli, I
    Laurenti, L
    Sorà, F
    Mele, L
    Annino, L
    Leone, G
    Sica, S
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (12) : 1915 - 1918
  • [5] Phase II trial of oral aminopterin for adults and children with refractory acute leukemia
    Cole, PD
    Drachtman, RA
    Smith, AK
    Cate, S
    Larson, RA
    Hawkins, DS
    Holcenberg, J
    Kelly, K
    Kamen, BA
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8089 - 8096
  • [6] Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia
    de Jonge, R
    Hooijberg, JH
    van Zelst, BD
    Jansen, G
    van Zantwijk, CH
    Kaspers, GJL
    Peters, FGJ
    Ravindranath, Y
    Pieters, R
    Lindemans, J
    [J]. BLOOD, 2005, 106 (02) : 717 - 720
  • [7] Cancer statistics, 2006
    Jemal, A
    Siegel, R
    Ward, E
    Murray, T
    Xu, JQ
    Smigal, C
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) : 106 - 130
  • [8] Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia
    Kishi, S
    Griener, J
    Cheng, C
    Das, S
    Cook, EH
    Pei, DQ
    Hudson, M
    Rubnitz, J
    Sandlund, JT
    Pui, CH
    Relling, MV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3084 - 3091
  • [9] Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia
    Krajinovic, M
    Lemieux-Blanchard, É
    Chiasson, S
    Primeau, M
    Costea, I
    Moghrabi, A
    [J]. PHARMACOGENOMICS JOURNAL, 2004, 4 (01) : 66 - 72
  • [10] Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis
    Krajinovic, M
    Costea, I
    Primeau, M
    Dulucq, S
    Moghrabi, A
    [J]. PHARMACOGENOMICS JOURNAL, 2005, 5 (06) : 374 - 380